查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1978929

生技设备市场：依设备类型、技术、应用、最终用户和销售管道划分－2026-2032年全球市场预测

Biotechnology Instrumentation Market by Instrument Type, Technology, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生技设备市场价值将达到 292.4 亿美元，到 2026 年将成长至 322.8 亿美元，到 2032 年将达到 595 亿美元，复合年增长率为 10.67%。

主要市场统计数据
基准年 2025 292.4亿美元
预计年份：2026年 322.8亿美元
预测年份 2032 595亿美元
复合年增长率 (%) 10.67%

清楚概述了重新定义整个生物技术生态系统中实验室采购行为和设备价值提案的因素。

生物技术仪器市场正处于十字路口，技术创新、不断变化的监管要求以及全球供应链的转变交织在一起，重塑实验室的营运和商业策略。产业相关人员越来越重视能够加速发现并缩短可靠数据获取时间的系统，而仪器供应商则透过模组化平台、整合软体和服务导向经营模式来应对这一需求。随着实验室对更高通量和可重复性的需求不断增长，仪器正从独立硬体转向融合本地运算、云端分析和远端诊断的网路生态系统。

数位化、单细胞技术创新以及服务导向的经营模式如何全面重塑产品设计和供应商差异化。

过去十年，我们在构思、采购和使用设备的方式上发生了翻天覆地的变化。首先，数位化已从边缘走向核心，内建软体和分析功能将单纯的硬体转变为资料工厂。如今，评估设备不仅看其光学和机械性能，还看其数据管道和API生态系统。因此，提供开放式互通架构的供应商越来越受欢迎，因为这些架构能够实现下游自动化和跨平台工作流程。

该评估评估了 2025 年关税变化如何重组筹资策略和时间表，并加速供应商多元化和在地化。

2025年，贸易政策的发展进一步加剧了全球供应链的摩擦，迫使设备製造商和科学研究机构重新评估其筹资策略和成本结构。关键零件和组件的关税调整增加了某些进口模组的到货成本，尤其是在依赖精密光学元件、专用电子元件和特定耗材的设备中。因此，供应链韧性成为重中之重，企业加快了供应商多元化、二级资讯认证以及在某些情况下采用近岸组装等策略，以减轻跨境关税的影响。

将设备类型、先进模式、应用优先顺序、最终用户趋势和通路连结起来的详细細項分析，形成可操作的商业策略。

要了解市场，需要对仪器类型、技术模式、应用案例、最终用户和通路进行深入观点，因为每个方面都决定了产品需求和商业性优先顺序。仪器类型细分包括层析法、显微镜、PCR 和光谱分析。层析法进一步细分为 FPLC、气相层析法和 HPLC；显微镜细分为共聚焦显微镜、电子显微镜和萤光显微镜；PCR 分为 dPCR 和 qPCR；光谱分析涵盖质谱、核磁共振和紫外-可见光光谱系统。技术细分将流式细胞技术、免疫检测、微阵列和定序确定为核心模式。流式细胞技术进一步细分为细胞计数和细胞分选功能；免疫分析分为化学发光免疫检测(CLIA) 和酶联免疫吸附试验 (ELISA) 平台；微阵列分为 DNA 专用阵列和蛋白质专用阵列；定序则区分为次世代定序和 Sanger 定序方法。

影响美洲、欧洲、中东和非洲以及亚太市场需求模式、合规要求和服务模式的区域趋势。

区域趋势对设备部署模式、监管合规性和服务生态系统结构有显着影响。美洲地区仍然是大型製药企业总部、转化研究中心和临床实验室网路的集中地，因此对高性能设备和整合服务合约的需求持续旺盛。在该地区，快速验证週期和强大的供应商支援网路备受重视，促使供应商设立本地维修设施并配备认证现场工程师，以最大限度地减少停机时间并加快部署速度。

整合平台策略、卓越服务和生态系统伙伴关係关係如何决定设备产业的竞争优势和客户维繫。

在设备领域，竞争优势越来越依赖将卓越的硬体、软体、耗材和全生命週期服务结合的整合解决方案。主要企业正透过投资检验的工作流程来脱颖而出，这些工作流程能够缩短从安装到获得可操作结果的时间；同时，他们也致力于开发能够实现资料标准化、远端监控和预测性维护的软体平台。与试剂和耗材供应商的伙伴关係，不仅能够增强持续的收入来源，还能透过完善的工作流程和检查室人员认证计画来提高客户留存率。

供应商面临的策略挑战是推动具有韧性的供应链、模组化创新和以客户为中心的经营模式，从而降低采用障碍。

领导企业应优先考虑三管齐下的策略，以平衡产品创新、供应链韧性和以客户为中心的经营模式。首先，投资于模组化硬体架构和开放式软体生态系统，以实现与各种实验室工作流程的快速整合。此类设计可缩短客製化时间，便于与第三方系统集成，并允许迭代式功能升级，而无需完全更换硬体。透过强调互通性，供应商可以支援协作研究环境，同时涵盖更广泛的应用领域。

透过结合对从业人员的访谈、技术分析和专家检验的严格混合方法，我们得出具有背景策略意义的见解。

本研究采用混合方法，结合一手质性访谈、二手文献整合和专家检验，以获得可靠且可操作的见解。研究人员对学术机构、生物技术公司、临床检查室和製药公司的设备经理、采购经理和研发经理进行了结构化访谈，作为一手资讯来源，以获取关于营运挑战、采购标准和服务期望的第一手观点。这些定性见解与大量同行评审文献、技术白皮书、监管指导文件和供应商技术规范进行交叉比对，以检验产品功能和部署注意事项。

策略概要强调平台适应性、服务深度和供应商韧性是永续部署和检查室连续性的基础。

总之，生物技术仪器产业正朝向整合化、服务导向平台转型，这些平台同等重视硬体效能和数位生态系统。检查室对仪器的互通性、易维护性和可预测的服务模式的需求日益增长，而供应商则必须在创新、供应链韧性和区域监管要求之间取得平衡。近期贸易政策调整的累积影响导致供应商多元化程度提高，并促使供应商更加关注区域製造，这进一步凸显了在采购谈判中采用透明、以总成本为导向的方法的必要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：生技设备市场：依设备类型划分

  • 层析法
    • FPLC
    • 气相层析法
    • HPLC
  • 显微镜
    • 共聚焦显微镜
    • 电子显微镜
    • 萤光显微镜
  • PCR
    • dPCR
    • qPCR
  • 光谱学
    • 质谱分析
    • 核磁共振波谱
    • 紫外-可见光谱

第九章：生物技术设备市场：依技术划分

  • 流式细胞技术
    • 细胞计数
    • 细胞分选
  • 免疫检测
    • CLIA
    • ELISA
  • 微阵列
    • DNA微阵列
    • 蛋白质微阵列
  • 定序
    • 次世代定序
    • 桑格定序

第十章：生技设备市场：依应用领域划分

  • 诊断
    • 临床诊断
    • 即时检测
  • 药物发现
    • 先导药物最适化
    • 目标识别
  • 基因组学
    • 基因表现
    • 突变分析
  • 蛋白质体学
    • 蛋白质定量
    • 蛋白质-蛋白质相互作用

第十一章：生技设备市场：依最终用户划分

  • 学术研究
  • 生技公司
  • 临床实验室
  • 合约研究机构
  • 製药

第十二章：生技设备市场：依销售管道划分

  • 直销
  • 销售代理
  • 线上销售

第十三章：生技设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：生技设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：生技设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国生技设备市场

第十七章：中国生物技术设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • Qiagen GmbH
  • Quest Diagnostics Incorporated
  • Roche Diagnostics GmbH
  • Sartorius AG
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Product Code: MRR-521BAA36EA70

The Biotechnology Instrumentation Market was valued at USD 29.24 billion in 2025 and is projected to grow to USD 32.28 billion in 2026, with a CAGR of 10.67%, reaching USD 59.50 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 29.24 billion
Estimated Year [2026] USD 32.28 billion
Forecast Year [2032] USD 59.50 billion
CAGR (%) 10.67%

A clear overview of the forces redefining laboratory purchasing behavior and instrumentation value propositions across the biotechnology ecosystem

The biotechnology instrumentation landscape sits at a crossroads where technological innovation, evolving regulatory expectations, and shifting global supply chains converge to reshape laboratory operations and commercial strategies. Industry stakeholders increasingly prioritize systems that accelerate discovery while reducing time to reliable data, and instrumentation suppliers are responding with modular platforms, integrated software, and service-oriented business models. As laboratories demand higher throughput and reproducibility, instruments are migrating from standalone hardware toward networked ecosystems that embed local compute, cloud analytics, and remote diagnostics.

This introduction outlines the critical forces influencing procurement priorities and product road maps within instrumentation. It synthesizes how end users-from academic research centers to large pharmaceutical R&D groups-are redefining value to include lifecycle support, integrated consumables, and guaranteed uptime. It also frames the competitive dynamics that favor firms able to deliver validated workflows, seamless software integrations, and scalable maintenance offerings. Taken together, these trends create both near-term operational challenges and medium-term opportunities for manufacturers to differentiate through lifecycle services, digital enablement, and strategic partnerships that align with laboratory modernization initiatives.

Throughout the report, readers will find analyses that connect product innovation with commercial strategies, enabling decision-makers to align investments in instrumentation with the evolving expectations of scientists, lab managers, and procurement officers.

How digitization, single-cell innovation, and service-oriented commercial models are collectively reshaping product design and vendor differentiation

The last decade has delivered transformative shifts that alter how instruments are conceived, purchased, and consumed. First, digitization has moved from peripheral to central, with embedded software and analytics transforming raw hardware into data factories. Instruments are now judged as much by their data pipelines and API ecosystems as by their optical or mechanical performance. Consequently, vendors who offer open, interoperable architectures gain traction, as they enable downstream automation and cross-platform workflows.

Second, sample-centric approaches such as single-cell analysis and spatial biology have driven demand for instruments that can capture complexity at scale. This has incentivized miniaturization, multiplexing capabilities, and higher sensitivity detectors. Meanwhile, the rise of automation and robotics has made throughput and standardization critical, prompting investment in integrated sample handling and validated workflows.

Third, commercial models are shifting toward outcome-based services and subscription frameworks that de-risk procurement for users while creating recurring revenue for suppliers. These models are often bundled with remote diagnostics and predictive maintenance, which reduce unplanned downtime and operational friction. Last, sustainability and regulatory scrutiny are influencing product design and supply chains, with manufacturers incorporating greener materials and traceability features to meet institutional purchasing mandates and compliance requirements.

Together, these shifts create a landscape where agility, software competence, and service excellence determine market leadership.

Evaluating how 2025 tariff changes have realigned sourcing strategies and procurement timelines while prompting accelerated supplier diversification and regionalization

In 2025, trade policy developments introduced additional friction into global supply chains, prompting instrument manufacturers and laboratory operators to reassess sourcing strategies and cost structures. Tariff adjustments on key components and assemblies have raised landed costs for certain imported modules, especially for instruments that rely on precision optics, specialized electronics, and certain consumable components. The immediate consequence has been a prioritization of supply chain resilience, with firms accelerating strategies to diversify suppliers, qualify secondary sources, and in some cases nearshore assembly to mitigate exposure to cross-border duties.

Parallel to sourcing changes, procurement timelines have lengthened as procurement officials and finance teams require greater transparency on total cost of ownership. Capital allocation now frequently factors in potential duty volatility and the administrative overhead associated with customs compliance. To preserve competitiveness, many vendors are reconfiguring bills of materials to substitute tariff-exposed parts with equivalent components that carry lower trade barriers, while simultaneously investing in local certifications and service footprints to reassure buyers.

Operationally, R&D organizations have responded by extending equipment validation cycles and by consolidating purchases to larger platform vendors who can offer bundled warranties and on-site service that reduce the risk of interruptions. Over time, regulatory dialogues between trading partners and industry consortia may ease transactional frictions, but in the near term the cumulative effect of tariffs has incentivized cost transparency, supplier diversification, and a renewed emphasis on regional manufacturing footprints to protect critical laboratory operations.

Deep segmentation analysis linking instrument types, advanced modalities, application priorities, end-user dynamics, and distribution pathways to actionable commercial strategies

Understanding the market requires a granular view of instrument types, technology modalities, use cases, end users, and distribution pathways because each axis informs product requirements and commercial priorities. Instrument Type segmentation spans Chromatography, Microscopy, PCR, and Spectroscopy, with Chromatography further differentiated into FPLC, Gas Chromatography, and HPLC; Microscopy subdivided into Confocal, Electron, and Fluorescence platforms; PCR categorized into dPCR and qPCR formats; and Spectroscopy encompassing Mass Spectrometry, NMR, and UV-Vis systems. Technology segmentation identifies Flow Cytometry, Immunoassays, Microarrays, and Sequencing as core modalities, where Flow Cytometry further bifurcates into cell counting and cell sorting capabilities, Immunoassays distinguishes CLIA and ELISA platforms, Microarrays separate DNA and protein-focused arrays, and Sequencing contrasts next-generation and Sanger approaches.

Application segmentation clarifies end-use priorities across Diagnostics, Drug Discovery, Genomics, and Proteomics, with Diagnostics delineated into clinical diagnosis and point-of-care testing, Drug Discovery separated into lead optimization and target identification, Genomics parsed into gene expression and variant analysis, and Proteomics into protein quantification and interaction studies. End User segmentation captures distinct purchasing dynamics across Academic Research, Biotechnology Companies, Clinical Laboratories, Contract Research Organizations, and Pharmaceutical entities, noting that Biotechnology Companies split into large and small biotech while Pharmaceutical customers differentiate between large and small pharma. Finally, Sales Channel segmentation highlights the role of direct-sales, distributors, online commerce, and retail channels, with distributor models further defined by systems integrators and value-added resellers.

These intersecting segmentations reveal where product design must align with workflow integration, where service and consumable strategies will influence retention, and where channel selection impacts time-to-deployment. For example, high-sensitivity spectroscopy systems destined for pharmaceutical labs require deep service networks and validated workflows, while sequencing platforms aimed at academic researchers benefit from modular pricing and open software ecosystems. Recognizing these nuances helps vendors tailor go-to-market strategies, prioritize R&D, and structure partnerships that reflect the distinct economics of each segment.

Regional dynamics shaping demand patterns, compliance requirements, and service models across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics materially influence instrument adoption patterns, regulatory compliance, and the structure of service ecosystems. The Americas continue to host a concentration of large pharmaceutical headquarters, translational research centers, and clinical laboratory networks, creating sustained demand for high-performance instrumentation and integrated service contracts. This region emphasizes rapid validation cycles and strong vendor support networks, which in turn incentivize suppliers to maintain local repair facilities and certified field engineers to minimize downtime and accelerate adoption.

In Europe, Middle East & Africa, procurement decisions are often shaped by a combination of stringent regulatory frameworks and funding models that reward reproducibility and sustainability. This influences buyers to favor instruments with strong compliance documentation, extended lifecycle support, and greener material choices. Vendors operating in this region must navigate diverse reimbursement and procurement rules while maintaining interoperability standards to serve multinational research consortia.

Asia-Pacific exhibits a heterogeneous mix of advanced research hubs and rapidly expanding diagnostic networks, with several markets prioritizing domestic manufacturing and indigenous innovation. The region's growth is propelled by heavy investment in genomics and biopharma R&D, yet it also presents variability in service maturity and regulatory pathways. Consequently, suppliers achieve success through flexible commercial models that combine localized manufacturing or assembly, capacity-building partnerships with local service providers, and tailored training programs to upskill laboratory personnel.

Across all regions, common cross-cutting themes include the need for robust digital support, scalable service operations, and regulatory alignment. Vendors that can adapt commercial terms to regional procurement practices and embed local support tend to outperform competitors in customer satisfaction and time-to-implementation.

How integrated platform strategies, service excellence, and ecosystem partnerships determine competitive advantage and customer retention in instrumentation

Competitive positioning in the instrumentation sector increasingly pivots on integrated offerings that combine hardware excellence with software, consumables, and lifecycle services. Leading firms differentiate through validated workflows that reduce the time from installation to actionable results, and by investing in software platforms that enable data standardization, remote monitoring, and predictive maintenance. Partnerships with reagent and consumable suppliers bolster recurring revenue while creating stickiness through locked-in workflows and certification programs for laboratory personnel.

Rising competitors are focused on niche innovations-such as ultra-high-throughput sample preparation modules, compact mass spectrometry units, or AI-driven image analysis engines-that displace legacy systems in specialized use cases. These challengers leverage agility and targeted investments to address unmet needs in single-cell profiling, spatial biology, and rapid diagnostics. Strategic alliances between instrument manufacturers and third-party software providers have become common, facilitating interoperability and accelerating time-to-results for integrated applications.

From a commercial standpoint, companies that can demonstrate measurable reductions in total operational friction-through bundled service agreements, transparent consumable pricing, and comprehensive training programs-gain preferential access to institutional purchasing channels. Furthermore, firms that align their road maps with regulatory trends and sustainability targets reinforce buyer confidence and open opportunities in public-sector procurement and large pharmaceutical partnerships. Overall, market leaders combine technological depth with scalable service delivery and ecosystem partnerships to sustain growth and protect margins in a competitive environment.

Strategic imperatives for vendors to drive resilient supply chains, modular innovation, and customer-aligned commercial models that reduce adoption friction

Leaders should prioritize a three-pronged approach that balances product innovation, supply chain resilience, and customer-centric commercial models. First, invest in modular hardware architectures and open-software ecosystems to enable rapid integration into diverse laboratory workflows. Such designs reduce customization time, facilitate third-party integrations, and allow iterative feature upgrades without wholesale hardware replacement. By emphasizing interoperability, vendors can capture a broader range of applications while supporting collaborative research environments.

Second, reinforce supply chain strategies by qualifying multiple component suppliers, pursuing regional manufacturing partnerships, and maintaining strategic component inventories for mission-critical product lines. These steps reduce exposure to tariff volatility and shorten lead times for replacement parts and consumables. In parallel, expand remote diagnostics and predictive maintenance capabilities to reduce costly on-site interventions and to improve uptime metrics for large end users.

Third, evolve commercial models to align incentives with customers through outcome-based contracts, subscription services for consumables, and hybrid service agreements that combine on-site support with remote analytics. Complement these offerings with comprehensive training and certification programs that reduce adoption friction and build long-term loyalty. Additionally, cultivate partnerships with local service providers and academic centers to enhance regional market penetration and ensure faster response times for technical support.

Taken together, these actions position suppliers to capture strategic opportunities while mitigating operational risk, enabling them to deliver both technical leadership and dependable commercial engagement.

Rigorous mixed-methods research combining practitioner interviews, technical synthesis, and expert validation to produce context-sensitive strategic insights

This research applied a mixed-methods approach combining primary qualitative interviews, secondary literature synthesis, and expert validation to ensure robust and actionable findings. Primary inputs included structured interviews with instrument managers, procurement leads, and R&D directors across academic, biotech, clinical laboratory, and pharmaceutical settings, which provided first-hand perspectives on operational pain points, procurement criteria, and service expectations. These qualitative insights were triangulated with an extensive review of peer-reviewed literature, technical white papers, regulatory guidance documents, and vendor technical specifications to validate product capabilities and deployment considerations.

Analytical methods included thematic coding of interview transcripts to surface recurring priorities, comparative assessment of product feature sets across instrument classes, and scenario analysis focused on supply chain and regulatory impacts. Regional comparisons leveraged demographic and institutional indicators to contextualize adoption dynamics. Findings were subjected to iterative expert review to refine conclusions and to ensure that recommendations align with practical constraints faced by laboratory operators and procurement groups.

Limitations include variability in procurement practices across institutions and the evolving nature of trade policy and regulatory guidance. To mitigate these constraints, the methodology emphasized cross-sector validation and sought corroboration from multiple stakeholders to improve the reliability of strategic insights presented throughout the report.

A strategic summary emphasizing platform adaptability, service depth, and supplier resilience as the foundations for sustained adoption and laboratory continuity

In conclusion, the biotechnology instrumentation sector is transitioning toward integrated, service-enabled platforms that place equal weight on hardware performance and digital ecosystems. Laboratories increasingly demand instruments that are interoperable, maintainable, and backed by predictable service models, while suppliers must reconcile innovation with supply chain resilience and regional regulatory expectations. The cumulative impact of recent trade policy adjustments has accelerated supplier diversification and regional manufacturing interest, reinforcing the need for transparent total-cost thinking in procurement conversations.

Segmentation analysis highlights that success depends on aligning product road maps to specific modality requirements and end-user workflows, whether serving high-throughput pharmaceutical discovery environments or resource-constrained academic labs. Regional dynamics necessitate tailored go-to-market approaches, blending local service presence with scalable digital support. Competitive differentiation will come from validated workflows, consumable economics, and software platforms that reduce operational friction and enable reproducible science.

For stakeholders across the ecosystem, the imperative is clear: invest in adaptable platforms, deepen service capabilities, and pursue strategic partnerships that accelerate adoption while protecting operational continuity. Those who execute on these priorities will be best positioned to capture demand and sustain long-term relationships with the laboratories that drive scientific progress.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biotechnology Instrumentation Market, by Instrument Type

  • 8.1. Chromatography
    • 8.1.1. FPLC
    • 8.1.2. Gas Chromatography
    • 8.1.3. HPLC
  • 8.2. Microscopy
    • 8.2.1. Confocal Microscopy
    • 8.2.2. Electron Microscopy
    • 8.2.3. Fluorescence Microscopy
  • 8.3. PCR
    • 8.3.1. dPCR
    • 8.3.2. qPCR
  • 8.4. Spectroscopy
    • 8.4.1. Mass Spectrometry
    • 8.4.2. NMR Spectroscopy
    • 8.4.3. UV-Vis Spectroscopy

9. Biotechnology Instrumentation Market, by Technology

  • 9.1. Flow Cytometry
    • 9.1.1. Cell Counting
    • 9.1.2. Cell Sorting
  • 9.2. Immunoassay
    • 9.2.1. CLIA
    • 9.2.2. ELISA
  • 9.3. Microarray
    • 9.3.1. DNA Microarray
    • 9.3.2. Protein Microarray
  • 9.4. Sequencing
    • 9.4.1. Next Generation Sequencing
    • 9.4.2. Sanger Sequencing

10. Biotechnology Instrumentation Market, by Application

  • 10.1. Diagnostics
    • 10.1.1. Clinical Diagnosis
    • 10.1.2. Point Of Care Testing
  • 10.2. Drug Discovery
    • 10.2.1. Lead Optimization
    • 10.2.2. Target Identification
  • 10.3. Genomics
    • 10.3.1. Gene Expression
    • 10.3.2. Variant Analysis
  • 10.4. Proteomics
    • 10.4.1. Protein Quantification
    • 10.4.2. Protein-Protein Interaction

11. Biotechnology Instrumentation Market, by End User

  • 11.1. Academic Research
  • 11.2. Biotechnology Companies
  • 11.3. Clinical Laboratories
  • 11.4. Contract Research Organizations
  • 11.5. Pharmaceutical

12. Biotechnology Instrumentation Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Sales

13. Biotechnology Instrumentation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biotechnology Instrumentation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biotechnology Instrumentation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Biotechnology Instrumentation Market

17. China Biotechnology Instrumentation Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Bio-Rad Laboratories, Inc.
  • 18.7. Bruker Corporation
  • 18.8. Danaher Corporation
  • 18.9. Illumina, Inc.
  • 18.10. Merck KGaA
  • 18.11. Oxford Nanopore Technologies PLC
  • 18.12. PerkinElmer, Inc.
  • 18.13. Qiagen GmbH
  • 18.14. Quest Diagnostics Incorporated
  • 18.15. Roche Diagnostics GmbH
  • 18.16. Sartorius AG
  • 18.17. Shimadzu Corporation
  • 18.18. Thermo Fisher Scientific Inc.
  • 18.19. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FPLC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FPLC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FPLC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GAS CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY HPLC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY HPLC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY HPLC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONFOCAL MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONFOCAL MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONFOCAL MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTRON MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTRON MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTRON MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DPCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DPCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DPCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NMR SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NMR SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NMR SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY UV-VIS SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY UV-VIS SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY UV-VIS SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL COUNTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL COUNTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL COUNTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL SORTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL SORTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CELL SORTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DNA MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DNA MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENE EXPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENE EXPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY VARIANT ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY VARIANT ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY VARIANT ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN QUANTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN QUANTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN QUANTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 282. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INSTRUMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MICROARRAY, 2018-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZ